title: Blast-derived microvesicles in sera from patients with acute myeloid leukemia suppress natural killer cell function via membrane-associated transforming growth factor-beta1.
abstract: BACKGROUND
  Natural killer cell cytotoxicity is decreased in patients with acute myeloid leukemia in comparison to that in normal controls. Tumor-derived microvesicles present in patients' sera exert detrimental effects on immune cells and may influence tumor progression.
  
  
  METHODS
  We investigated the microvesicle protein level, molecular profile and suppression of natural killer cell activity in patients with newly diagnosed acute myeloid leukemia.
  
  
  RESULTS
  The patients' sera contained higher levels of microvesicles compared to the levels in controls (P<0.001). Isolated microvesicles had a distinct molecular profile: in addition to conventional microvesicle markers, they contained membrane-associated transforming growth factor-β1, MICA/MICB and myeloid blasts markers, CD34, CD33 and CD117. These microvesicles decreased natural killer cell cytotoxicity (P<0.002) and down-regulated expression of NKG2D in normal natural killer cells (P<0.001). Sera from patients with acute myeloid leukemia contained elevated levels of transforming growth factor-β, and urea-mediated dissociation of microvesicles further increased the levels of this protein. Neutralizing anti-transforming growth factor-β1 antibodies inhibited microvesicle-mediated suppression of natural killer cell activity and NKG2D down-regulation. Interleukin-15 protected natural killer cells from adverse effects of tumor-derived microvesicles.
  
  
  CONCLUSIONS
  We provide evidence for the existence in acute myeloid leukemia of a novel mechanism of natural killer cell suppression mediated by tumor-derived microvesicles and for the ability of interleukin-15 to counteract this suppression.
authors: University of Pittsburgh Cancer Institute, Pittsburgh, PA 15232 USA.
authors: Miroslaw J
authors: MJ
authors: Szczepanski
authors: Marta
authors: M
authors: Szajnik
authors: Ann
authors: A
authors: Welsh
authors: Theresa L
authors: TL
authors: Whiteside
authors: Michael
authors: M
authors: Boyiadzis
references: PLoS One. 2010 Jul 22;5(7):e11469
references: 20661468
references: J Immunol. 2004 Jun 15;172(12):7335-40
references: 15187109
references: Lancet. 2002 Jul 27;360(9329):295-305
references: 12147373
references: Nature. 2002 Oct 17;419(6908):734-8
references: 12384702
references: Blood Cells Mol Dis. 2006 Mar-Apr;36(2):315-21
references: 16487731
references: J Immunol. 2008 Jun 1;180(11):7249-58
references: 18490724
references: Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):4120-5
references: 12646700
references: Gastroenterology. 2007 Mar;132(3):994-1008
references: 17324400
references: Cell Death Differ. 2008 Jan;15(1):80-8
references: 17932500
references: Blood. 2002 Nov 15;100(10):3633-8
references: 12393617
references: J Immunol. 2006 Feb 1;176(3):1375-85
references: 16424164
references: Blood. 2000 Dec 15;96(13):4075-83
references: 11110676
references: Cancer Res. 2007 Apr 1;67(7):2912-5
references: 17409393
references: Cancer Immunol Immunother. 2010 Jan;59(1):73-9
references: 19526239
references: Methods. 1996 Apr;9(2):316-26
references: 8812685
references: J Immunol. 2008 Sep 15;181(6):3784-92
references: 18768831
references: J Clin Invest. 1997 Mar 1;99(5):937-43
references: 9062351
references: Cell Cycle. 2009 Jul 1;8(13):2014-8
references: 19535896
references: Clin Cancer Res. 2005 Feb 1;11(3):1010-20
references: 15709166
references: Blood. 2005 May 1;105(9):3615-22
references: 15657183
references: Blood. 2007 Jan 1;109(1):323-30
references: 16940427
references: Biol Blood Marrow Transplant. 2008 Mar;14(3):290-300
references: 18275895
references: Blood. 2003 Jun 15;101(12):4887-93
references: 12586624
references: Blood. 2008 Aug 1;112(3):461-9
references: 18650461
references: Head Neck. 2009 Mar;31(3):371-80
references: 19073006
references: Blood. 2002 May 15;99(10):3661-7
references: 11986221
references: Trends Immunol. 2010 Jun;31(6):220-7
references: 20538542
references: J Immunol. 2009 Sep 15;183(6):3720-30
references: 19692638
references: J Clin Lab Anal. 1990;4(2):102-14
references: 2179501
references: Int J Cancer. 2009 Jun 1;124(11):2621-33
references: 19235923
references: Immunol Res. 2006;36(1-3):247-54
references: 17337785
references: J Cell Sci. 2000 Oct;113 Pt 19:3365-74
references: 10984428
references: Cancer Res. 2010 Jan 15;70(2):481-9
references: 20068167
references: Clin Cancer Res. 2003 Nov 1;9(14):5113-9
references: 14613988